Inhaled nitric oxide and inhaled prostaglandin E 1 : effect on left ventricular contractility when used for treatment of experimental pulmonary hypertension

By Krieg P.   Wahlers T.   Giess W.   Rohde R.   Hartrumpf M.   Bund M.   Haverich A.  

European Journal of Cardio-Thoracic Surgery, Vol. 14, Iss. 5, 1998-11 ,pp. : 494-502

Elsevier

Access to resources Recommend Favorite

Pulmonary Hypertension in Dialysis Patients

By Kosmadakis George   Aguilera Didier   Carceles Odette   Da Costa Correia Enrique   Boletis Ioannis  

Renal Failure, Vol. 35, Iss. 4, 2013-05 ,pp. : 514-520

Informa Healthcare

Access to resources Recommend Favorite

Pulmonary Hypertension in Dialysis Patients

By Oygar Duriye Deren   Zekican Guzin  

Renal Failure, Vol. 34, Iss. 7, 2012-08 ,pp. : 840-844

Informa Healthcare

Access to resources Recommend Favorite

Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance

By Sablotzki A.   Hentschel T.   Gruenig E.   Schubert S.   Friedrich I.   Muhling J.   Dehne M.G.   Czeslick E.  

European Journal of Cardio-Thoracic Surgery, Vol. 22, Iss. 5, 2002-11 ,pp. : 746-752

Elsevier

Access to resources Recommend Favorite

Appetite-suppressant Drugs and the Risk of Primary Pulmonary Hypertension?

By Deitel Mervyn  

Obesity Surgery, Vol. 7, Iss. 1, 1997-02 ,pp. : 3-4

Springer Publishing Company

Access to resources Recommend Favorite